POLI and hereditary disease: While gain of function mutations affecting PolI components are not frequent and are mostly associated with hereditary diseases rather than with cancer [22,23], tumor cells boost rRNA biogenesis mainly through the overexpression of genes involved in PolI-mediated transcription and through the stimulation of their activity, which is directly controlled by oncogenic signaling pathways.